GSK press releases Follow GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline Agreement reinforces GSK’s portfolio in the treatment of lupus and underlying drivers of autoimmune disease https://www.gsk.com/en-gb/media/press-releases/gsk-enters-agreement-to-acquire-cmg1a46-from-chimagen-biosciences/ gsk.com
